Free Trial

Stoke Therapeutics (STOK) SEC Filings & 10K Form

Stoke Therapeutics logo
$9.63 -0.24 (-2.43%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$9.63 0.00 (0.00%)
As of 05/2/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Stoke Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2025
5:41 PM
BlackRock, Inc. (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
04/15/2025
4:04 PM
BlackRock Portfolio Management LLC (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G
03/20/2025
5:15 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:16 PM
LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:17 PM
Leggett Thomas (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:18 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:19 PM
SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:05 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:12 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:05 PM
Stoke Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
3:07 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:08 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
3:31 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
3:36 PM
MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
01/07/2025
6:06 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:14 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:23 PM
Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13D/A
12/27/2024
4:13 PM
Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
5:15 PM
Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:05 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:07 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:59 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4/A
12/10/2024
6:00 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:01 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:02 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:48 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:19 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:19 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:20 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:21 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:24 PM
BAKER BROS. ADVISORS LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G
11/14/2024
8:00 AM
Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
11/05/2024
3:15 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:05 PM
Stoke Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:56 PM
Stoke Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:50 PM
Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:16 PM
Stoke Therapeutics (Filer)
Form S-3ASR
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
09/23/2024
3:22 PM
Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
Form SC 13D/A
09/23/2024
3:23 PM
Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
4:23 PM
Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:20 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G
06/20/2024
11:15 PM
Stoke Therapeutics (Filer)
Form EFFECT
06/13/2024
3:06 PM
Stoke Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
3:42 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:32 PM
Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:35 PM
Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:37 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:39 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:41 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:27 PM
Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:29 PM
Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:16 PM
Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:18 PM
LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:19 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:15 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:17 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:20 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:21 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STOK) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners